| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |